Quick Answer
Roivant Sciences Ltd. reported Shares Outstanding of 695.94 million shares for fiscal year 2025.
Roivant Sciences Ltd. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 695.94M | -13.7% |
| 2024 | 806.68M | +6.1% |
| 2023 | 760.14M | +9.4% |
| 2022 | 694.98M | +6.7% |
| 2021 | 651.58M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | 709.69M | -1.4% | +2.9% |
| September 30, 2025 | 689.70M | -5.9% | +1.1% |
| June 30, 2025 | 682.23M | -7.7% | -2.0% |
| March 31, 2025 | 695.94M | -13.7% | -3.3% |
| December 31, 2024 | 719.63M | -10.6% | -1.9% |
| September 30, 2024 | 733.33M | -8.4% | -0.8% |
| June 30, 2024 | 739.05M | -3.7% | -8.4% |
| March 31, 2024 | 806.68M | +6.1% | +0.2% |
- Roivant Sciences Ltd. showed a decrease of -13.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2021–2025 period, Roivant Sciences Ltd.’s shares outstanding has grown by 6.8% (from 651.58 million shares to 695.94 million shares).
- The most recent figure is from Roivant Sciences Ltd.’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: